136 related articles for article (PubMed ID: 31972789)
21. RELATIONSHIP OF CLINICAL FEATURES AND BASELINE TUMOR SIZE WITH GENE EXPRESSION PROFILE STATUS IN UVEAL MELANOMA: A Multi-institutional Study.
Berry D; Seider M; Stinnett S; Mruthyunjaya P; Schefler AC;
Retina; 2019 Jun; 39(6):1154-1164. PubMed ID: 29578940
[TBL] [Abstract][Full Text] [Related]
22. Clinicopathological Characteristics and Prognosis for Survival after Enucleation of Uveal Melanoma in Chinese Patients: Long-term Follow-up.
Yue H; Qian J; Yuan Y; Zhang R; Bi Y; Meng F; Xuan Y
Curr Eye Res; 2017 May; 42(5):759-765. PubMed ID: 27911584
[TBL] [Abstract][Full Text] [Related]
23. PRDX3 is associated with metastasis and poor survival in uveal melanoma.
Ramasamy P; Larkin AM; Linge A; Tiernan D; McAree F; Horgan N; Moriarty P; Beatty S; Murphy CC; Clynes M; Kennedy S; Meleady P
J Clin Pathol; 2020 Jul; 73(7):408-412. PubMed ID: 31771972
[TBL] [Abstract][Full Text] [Related]
24. Ten-year outcomes of uveal melanoma based on The Cancer Genome Atlas (TCGA) classification in 1001 cases.
Shields CL; Mayro EL; Bas Z; Dockery PW; Yaghy A; Lally SE; Ganguly A; Shields JA
Indian J Ophthalmol; 2021 Jul; 69(7):1839-1845. PubMed ID: 34146040
[TBL] [Abstract][Full Text] [Related]
25. PRiMeUM: A Model for Predicting Risk of Metastasis in Uveal Melanoma.
Vaquero-Garcia J; Lalonde E; Ewens KG; Ebrahimzadeh J; Richard-Yutz J; Shields CL; Barrera A; Green CJ; Barash Y; Ganguly A
Invest Ophthalmol Vis Sci; 2017 Aug; 58(10):4096-4105. PubMed ID: 28828481
[TBL] [Abstract][Full Text] [Related]
26. Clinical Features, Metastasis, and Survival in Patients Younger Than 21 Years With Posterior Uveal Melanoma.
Fry MV; Augsburger JJ; Corrêa ZM
JAMA Ophthalmol; 2019 Jan; 137(1):75-81. PubMed ID: 30422230
[TBL] [Abstract][Full Text] [Related]
27. Uveal melanomas in black patients: a case series and comparative review.
Phillpotts BA; Sanders RJ; Shields JA; Griffiths JD; Augsburger JA; Shields CL
J Natl Med Assoc; 1995 Sep; 87(9):709-14. PubMed ID: 9583969
[TBL] [Abstract][Full Text] [Related]
28. Clinical predictors of survival in metastatic uveal melanoma.
Lorenzo D; Piulats JM; Ochoa M; Arias L; Gutiérrez C; Català J; Cobos E; Garcia-Bru P; Dias B; Padrón-Pérez N; Caminal JM
Jpn J Ophthalmol; 2019 Mar; 63(2):197-209. PubMed ID: 30796549
[TBL] [Abstract][Full Text] [Related]
29. Uveal metastasis in 1111 patients: Interval to metastasis and overall survival based on timing of primary cancer diagnosis.
Welch RJ; Malik K; Mayro EL; Newman JH; Honig SE; Ang SM; Selzer EB; Acaba-Berrocal LA; McGarrey MP; Graf AE; Considine SP; Shields JA; Shields CL
Saudi J Ophthalmol; 2019; 33(3):229-237. PubMed ID: 31686963
[TBL] [Abstract][Full Text] [Related]
30. Nationwide Incidence of Ocular Melanoma in South Korea by Using the National Cancer Registry Database (1999-2011).
Park SJ; Oh CM; Kim BW; Woo SJ; Cho H; Park KH
Invest Ophthalmol Vis Sci; 2015 Jul; 56(8):4719-24. PubMed ID: 26207308
[TBL] [Abstract][Full Text] [Related]
31. Uveal melanoma: Long-term survival.
Radivoyevitch T; Zabor EC; Singh AD
PLoS One; 2021; 16(5):e0250939. PubMed ID: 34003826
[TBL] [Abstract][Full Text] [Related]
32. Survival in patients with uveal melanoma in Europe.
Virgili G; Gatta G; Ciccolallo L; Capocaccia R; Biggeri A; Crocetti E; Lutz JM; Paci E;
Arch Ophthalmol; 2008 Oct; 126(10):1413-8. PubMed ID: 18852420
[TBL] [Abstract][Full Text] [Related]
33. Prognostic Factors and Decision Tree for Long-Term Survival in Metastatic Uveal Melanoma.
Lorenzo D; Ochoa M; Piulats JM; Gutiérrez C; Arias L; Català J; Grau M; Peñafiel J; Cobos E; Garcia-Bru P; Rubio MJ; Padrón-Pérez N; Dias B; Pera J; Caminal JM
Cancer Res Treat; 2018 Oct; 50(4):1130-1139. PubMed ID: 29198096
[TBL] [Abstract][Full Text] [Related]
34. Visual Outcome at 4 Years Following Plaque Radiotherapy and Prophylactic Intravitreal Bevacizumab (Every 4 Months for 2 Years) for Uveal Melanoma: Comparison With Nonrandomized Historical Control Individuals.
Shields CL; Dalvin LA; Chang M; Mazloumi M; Fortin P; McGarrey M; Martin A; Yaghy A; Yang X; Vichitvejpaisal P; Mashayekhi A; Shields JA
JAMA Ophthalmol; 2020 Feb; 138(2):136-146. PubMed ID: 31830238
[TBL] [Abstract][Full Text] [Related]
35. Metastatic tumours to the eye. Review of metastasis to the iris, ciliary body, choroid, retina, optic disc, vitreous, and/or lens capsule.
Shields CL; Kalafatis NE; Gad M; Sen M; Laiton A; Silva AMV; Agrawal K; Lally SE; Shields JA
Eye (Lond); 2023 Apr; 37(5):809-814. PubMed ID: 35306540
[TBL] [Abstract][Full Text] [Related]
36. Gender differences in clinical presentation and prognosis of uveal melanoma.
Zloto O; Pe'er J; Frenkel S
Invest Ophthalmol Vis Sci; 2013 Jan; 54(1):652-6. PubMed ID: 23197684
[TBL] [Abstract][Full Text] [Related]
37. Incidence of uveal melanoma in Europe.
Virgili G; Gatta G; Ciccolallo L; Capocaccia R; Biggeri A; Crocetti E; Lutz JM; Paci E;
Ophthalmology; 2007 Dec; 114(12):2309-15. PubMed ID: 17498805
[TBL] [Abstract][Full Text] [Related]
38. Long-term Risk of Melanoma-Related Mortality for Patients With Uveal Melanoma Treated With Proton Beam Therapy.
Lane AM; Kim IK; Gragoudas ES
JAMA Ophthalmol; 2015 Jul; 133(7):792-6. PubMed ID: 25905597
[TBL] [Abstract][Full Text] [Related]
39. Uveal melanoma among Finnish children and young adults.
Al-Jamal RT; Kivelä T
J AAPOS; 2014 Feb; 18(1):61-6. PubMed ID: 24568985
[TBL] [Abstract][Full Text] [Related]
40. Uveal melanoma in the first 4 decades of life.
Sagus M; Bedikian AY
South Med J; 2015 Mar; 108(3):158-63. PubMed ID: 25772049
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
